In silico analysis of protein neoplastic biomarkets for cervix and uterine cancer
Miguel Ángel Rodríguez Pérez
págs. 604-617
Genetic modelling of the PTEN/AKT pathway in cancer research
Oliver Renner, Carmen Blanco Aparicio, Amancio Carnero
págs. 618-627
Pharmacogenomics: a tool for improving cancer chemotherapy
Gerardo Ferrer
págs. 628-637
Options for radiotherapy in the treatment of liver metastases
Joan Manuel Gasent Blesa, Laura A. Dawson
págs. 638-645
Tumour molecular subtyping according to hormone receptors and HER2 status different pathological complete response to neoadjuvant chemotherapy in patients with locallu advanced breast cancer
Alfonso Sánchez Muñoz
págs. 646-653
Sensitivity to change of the Spanish validated Memorial Pain Assessment Card in cancer patients
Jorge Contreras Martínez
págs. 654-659
Risk.reduction surgery in BRCA mutation carries in a Spanish population: adherence and results
Pedro Pérez Segura
págs. 660-664
Idiopathic and recurrent thromboembolic phenomena in cancer patients
Miriam López Gómez
págs. 665-669
Skull base chondrosarcoma: a case treated by the Cyberknife system
Julio José Lambea Sorrosal
págs. 670-672
Primary ovarian Burkitt Lymphoma
Andrés Jesús Muñoz Martín
págs. 673-675
Endotracheal metastases from colon adenocarcinoma
José Marcelo Galbis Caravajal
págs. 676-678
Role of radiotherapy in organ-sparing treatment of seminoma
Amanda Flaquer
págs. 679-681
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: